Subtle Medical's new software is now available for clinical use in the US, further redefining the speed and quality of accelerated MRI
Subtle Medical, a leading healthcare technology company using AI to improve medical imaging, announced FDA clearance of their new software solution, SubtleSYNTH™, which uses deep learning (DL) to generate...
nference announced a strategic research alliance with Takeda aimed at harnessing artificial intelligence (AI) to optimize patient care in inflammatory bowel disease (IBD), a chronic gastrointestinal disorder affecting millions globally.
The collaboration, known as Project SUCCINCT (Systematic UC & Crohn’s INformatics Clinical Toolkit), will utilize nference’s advanced machine learning models to analyze de-identified electronic health records....
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list.
Hyperfine, the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—announced the clearance of the ninth generation...
CytoReason, a leader in developing computational disease models for predictive insights, announced it secured an aggregated $80 million from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific.
CytoReason will use this investment to expand the application of its models into additional indications, grow its proprietary molecular and clinical data, and establish...
Tempus AI, Inc., a leader in artificial intelligence and precision medicine, announced that its multimodal immune profile score (IPS) algorithmic test is now available for research use only (RUO). IPS is the first offering of a larger immunotherapy-based portfolio being developed at Tempus to bring next-generation algorithmic diagnostics to...
Circle Cardiovascular Imaging, the global leader in AI-driven cardiovascular imaging solutions, announced that Erkan Akyuz has been appointed Chief Executive Officer, effective August 5, 2024. He will succeed Circle co-founder and CEO Greg Ogrodnick, who is stepping down after successfully leading the Company for more than 16 years.
Akyuz brings extensive...
Monod Bio, a life sciences company using AI to generate new proteins for the research use only (RUO) and in vitro diagnostics (IVD) markets, announced the launch of the LuxSit™ Pro family of products, the world's smallest and first commercially-available de novo luciferases, which are light-emitting enzymes that use...
Mendel AI, a leader in clinical AI for the life sciences industry, announced it has joined NVIDIA Inception, a program that nurtures startups revolutionizing industries with technological advancements.
By joining NVIDIA Inception, Mendel will receive access to NVIDIA’s industry-leading technology, including the latest NVIDIA NIM inference microservices to accelerate Mendel's Hypercube AI solution,...
Digital workflows help to improve diagnostic accuracy and efficiency by integrating pathology into broader precision diagnostic systems and IT infrastructure
Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort more than in any other area of medicine. It involves a multidisciplinary team of oncologists, pathologists,...
Spotlight Medical, a pioneering startup developing AI-driven prognosis tests to assist physicians in selecting the most effective treatment for cancer patients, announced that it has raised €6.2 million in a seed funding round. The investment was led by Kurma Partners and Heal Capital.'
This funding will enable Spotlight Medical to...
